Non-Small-Cell Lung Cancer (NSCLC)
Conditions
Interventions
DC loaded Livin + radiotherapy group:immunotherapy and radiotherapy
DC loaded MUC-1 + radiotherapy group:immunotherapy and radiotherapy
Sponsors
Cancer Institute of People's Liberation Army, Third Military Medical University Xinqiao hospital
Eligibility
Sex/Gender
All
Age
30 Years to 60 Years
Inclusion criteria
Inclusion criteria: 1. Confirmed non-small-cell lung cancer (NSCLC) by pathological and histological/cytologic examination; 2. Performance status is good, PS3 months; 4. 18 years old or over 18 years old; 5. Always have responded to radiotherapy; 6. Always have responded to autoimmune cellular therapy; 7. The liver function, renal, bone marrow was essentially normal; 8. Chemotherapy and molecular targeted therapy clearance phase should be 2 weeks or more; 9. The patient volunteered to conduct the study, and good compliance, could cooperate to observation of experiments, and freely given informed consent.
Exclusion criteria
Exclusion criteria: 1. Severe dysfunction of life viscera; 2. Associated with other malignant tumor; 3. Have autoimmune diseases; 4. During pregnancy and nursing (women of reproductive age Should do a pregnancy test); 5. During active stage of acute or chronic infectious diseases; 6. Have clear allergic history in medicine or belong to allergies; 7. Actively participate in other clinical trials; 8. Those determined by the researchers to be unsuitable to participate in the (clinical) trial or under certain conditions.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| immtmity indicator;clinical indicators;the toxic and side effect; | — |
Countries
China
Contacts
Public ContactJianguo Sun
Outcome results
None listed